Consun Pharmaceutical Group (FRA:C1P) Accounts Payable & Accrued Expense : €59.2 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Accounts Payable & Accrued Expense?

Consun Pharmaceutical Group's quarterly accounts payable & accrued expense declined from Dec. 2023 (€57.4 Mil) to Jun. 2024 (€40.4 Mil) but then increased from Jun. 2024 (€40.4 Mil) to Dec. 2024 (€59.2 Mil).

Consun Pharmaceutical Group's annual accounts payable & accrued expense increased from Dec. 2022 (€53.7 Mil) to Dec. 2023 (€57.4 Mil) and increased from Dec. 2023 (€57.4 Mil) to Dec. 2024 (€59.2 Mil).

Consun Pharmaceutical Group Accounts Payable & Accrued Expense Historical Data

The historical data trend for Consun Pharmaceutical Group's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Accounts Payable & Accrued Expense Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

46.59

48.58

53.72

57.35

59.22

Consun Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															53.72	37.47	57.35	40.35	59.22

Consun Pharmaceutical Group Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Consun Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (FRA:C1P) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

CPHGF:USA 01681:Hong Kong

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group Headlines

No Headlines